Neospora caninum qPCR Kit

Neospora caninum qPCR Kit (CAT#: PRPK-034)

Product Type
Kit
Unit Size
100 T
Description
The Neospora caninum qPCR kit has been specifically created for the in vitro identification of N. caninum genomes. With a focus on maintaining specificity to N. caninum, the kit boasts a wide-ranging detection capability. It has been meticulously designed to inclusively and exclusively detect this particular species in vitro. The primer and probe sequences exhibit significant homology (>95%) with a diverse array of N. caninum genomes, validated through extensive bioinformatic analysis using reference data within the NCBI database. Notably, this kit does not detect other closely related species. While designed and validated to meet the rigorous criteria of a quantitative assay, it's important to highlight that the provided positive control is not meant for quantification purposes.
Nucleic Acid Target
DNA
Compatibility
All standard real-time thermal cyclers
Target Species
Neospora caninum
Detection Method
Probe based
Features
Free automatic data analyzer (Fastfinder)
Components
qPCR master mix (2x)
qPCR master mix reconstitution buffer
PPMix (10x)
NTC
Positive control
DNA internal extraction control (IEC)
Format
Lyophilized
Technology
Predesigned qPCR assays
Sample Material
DNA
Protocol Time
Approx. 60 min (from extracted NA to result)
Number of Targets
Duplex
Internal Control
No
Storage Conditions
-85 °C to -15 °C
Regulatory Status
For research use only.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Ace Therapeutics is a contract service provider focused on parasitology research, providing innovative solutions and technologies for parasite detection, genetic engineering, and drug development. We support global research institutes, universities, and pharmaceutical companies in advancing their research goals.

Contact Info
Inquiry
Copyright © Ace Therapeutics. All Rights Reserved.
Top